Affordable Access

Semi-extended, six weekly rituximab infusions in pre-treated advanced low-grade B cell non-Hodgkin's lymphoma: a phase II study.

Authors
Type
Published Article
Journal
Anti-Cancer Drugs
0959-4973
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
14
Issue
10
Pages
809–815
Identifiers
PMID: 14597875
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments